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Introduction
Treatment of an abdominal aortic aneurysm (AAA) by endo-
vascular aneurysm repair (EVAR) has good postoperative out-
come.1 Long-term risks includemigrationof the endograft and
Type Ia endoleak, whose occurrence depends on anatomic
characteristics of the aortic neck and the type of endovascular
device used.2,3 Infection of the implanted endograft can also
occur.4 There is general agreement that invasive treatment is
thebestoptionto treat these infectionsbecauseofan increased
risk of rupture compared with when they are left untreated.5
The most durable solution includes full explantation of the
endograft. This is not always feasible because of patient
characteristics, including aortic anatomy, hostile abdomen,
and comorbidities. As a consequence, long-term antibiotic
suppressive therapy may serve as the second best.
We present a case of a Type Ia endoleak after EVAR in a
patient highly suspected of having an infection of the
endograft.
Case Presentation
An 81-year-old man presented to the emergency room with
fever, 5 years after EVAR for an infrarenal AAA of 54 mm in
diameterwith aGore ExcluderAAAEndoprosthesis (W.L. Gore
& Associates, Inc., Flagstaff, AZ). During follow-up, a Type II
endoleak in a stable aneurysm sac diameter was accepted.
Three years prior to presentation, the patient was treatedwith
an infragenicular femoropopliteal polytetraﬂuoroethylene
(PTFE) bypass for an acute occlusion of a left popliteal artery
aneurysm (PAA). A PAA on the right side was treated with a
reversed autologous saphenous vein bypass. Prior to presenta-
tion, the patient was treated with ciproﬂoxacin by his family
physician for a urinary tract infection. In-hospital urine cul-
tures taken at presentation showed ciproﬂoxacin-resistant
infection with Klebsiella pneumoniae.
At presentation the patient had fever up to 40°C. Labora-
tory examination showed plasma C-reactive protein (CRP)










Abstract An 81-year-old patient presented to the emergency room 5 years after infrarenal
endovascular aneurysm repair, with a Type Ia endoleak and a presumable infection of
the graft material with Listeria monocytogenes. He was treated with a custom-made
fenestrated endograft to seal the endoleak and lifelong antibiotic therapy to suppress
the infection. Full explantation of graft material is not always preferable, and
endovascular treatment combined with antibiotic suppressive therapy is in some
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12.3  109/L. Because of an unclear focus for the infection,
18F-ﬂuorodeoxyglucose–positron emission tomography
(18F-FDG–PET), combined with computed tomography
angiography (CTA), was made. Increased FDG uptake on
the PET scan was seen at the level of the proximal end and
bifurcation of the aortic endograft and at the left PAA sac. All
three locations had clear elevations in maximum standard
uptake value (SUVmax) and tissue-to-background ratio
(►Fig. 1). In addition, a Type Ia endoleak was diagnosed
with an increase in the aneurysmal sac diameter from 66 to
72 mm as compared with the duplex ultrasound 14 months
earlier.
Oral ciproﬂoxacin was switched to intravenous merope-
nem for wider pathogen coverage at admission. Puncture of
the left PAA was done 8 days after admission. Culture of the
aspirated material revealed Listeria monocytogenes only
intermediately sensitive to meropenem, but sensitive for
amoxicillin and cotrimoxazole, after which the antibiotic
regimen was changed to this combination. After this switch,
the fever subsided. The left PAA sac was opened surgically
and cleaned (►Fig. 2). Amoxicillin was administered for 4
weeks intravenously and oral cotrimoxazole lifelong. Ten
weeks after presentation, fever was still absent, plasma CRP
level declined to a level of 38 mg/L, and WBC declined to
5.2  109/L.
Fig. 1 Coronal orientation of 18F-ﬂuorodeoxyglucose (18F-FDG) positron emission tomography (PET) (A) and CT scan (B and C). Clear uptake in
the 18F-FDG–PETscan can be seen at the upper part (maximum standard uptake value [SUVmax] 10.74; tissue-to-background ratio [TBR] 7.83) and
at the bifurcation (SUVmax 8.28; TBR 6.04) of the endoprosthesis, and at the level of the treated left popliteal aneurysm (SUVmax 6.54; TBR 4.77).
Fig. 2 Photograph after opening and cleaning the infected left
popliteal aneurysm. Delayed wound healing can be seen and central
wound separation after staple removal. Secondary wound healing was
later seen at the outpatient clinic.
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Considering the patient’s age and infections of both
abdominal and popliteal vascular graft, an open surgical
procedure to treat the Type Ia endoleak and remove the
endograft was not an option. The infrarenal sealing zonewas
only 8 mm in length; therefore, repair with a fenestrated
AnacondaAAA stent graft (Vascutek Ltd. Inchinnan, Scotland,
United Kingdom) was chosen. The bi-iliac device contained
fenestrations for both renal arteries and a fenestration for the
superior mesenteric artery situated between the two prox-
imal sealing rings (►Fig. 3).
Fig. 3 Before (left) and after (right) placement of the fenestrated Anaconda abdominal aortic aneurysm stent graft. Before treatment, another
endograft for infrarenal endovascular aneurysm repair and an endoleak can be seen (A, C). After placement of the bi-iliac fenestrated Anaconda
with stents inside the both renal arteries and the superior mesenteric artery, no endoleak was present (B, D).
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For this procedure, a cutdown of both groins was per-
formed to get access to both common femoral arteries. All
three fenestrations were stented successfully, and no endo-
leak was present at completion angiography. The postopera-
tive period was uneventful, and the patient was discharged
from the hospital 3 days later. He is kept under lifelong oral
antibiotic therapy with cotrimoxazole. CTA at 6 weeks did
not show any endoleak or graft failure. After 3 months, no
fever or events were reported, plasma CRP level was 9 mg/L,
and WBC 5.3  109/L.
Discussion
This case demonstrates the difﬁculties that may occur in
clinical decision making when patients unﬁt for open repair
are faced with multiple problems such as a large Type Ia
endoleak after EVAR presumably complicated by an infection
of the endograft.
Endovascular graft infection is rare, occurring in 0.6% of
the cases and fatal in 63% when left untreated.4 The greatest
risk is contamination during the primary surgical procedure.
Most infectious organisms are similar to those cultured in
mycotic aneurysms, being Staphylococcus aureus in 43%,
Escherichia coli in 17%, and Staphylococcus epidermidis in
10% of the cases.4,6
Physical examination, chest X-ray, urine analysis, and
blood cultures are standard to search for the focus in patients
with suspicion of an infection. When these patients have
concurrent endovascular grafts, colonization should be sus-
pected, if the focus cannot be found or they are unresponsive
to treatment. Standard follow-up of patients with an endo-
vascular graft is usually done with CTA and duplex ultra-
sound, but these modalities do not always accurately show
endovascular graft infections. The use of 18F-FDG–PET scan-
ning, combined with CT scanning, can help diagnose endo-
vascular graft infections.7
An infectionwith L. monocytogenes is also uncommon, and
presentation can vary from fever and gastroenteritis to sepsis
and meningitis. The origin is usually food based. Moreover,
cattle farm residents have a higher risk of infection.8
An endograft infected with L. monocytogenes has only
been described in two cases, emphasizing the unusual
combination. In the ﬁrst case, it concerned a 77-year-old
patient, treated by en bloc resection of endograft and aneur-
ysm and subsequent reconstruction.9 The second case
described by our group was a 67-year-old man in whom
ﬂuid collections around the endograft, based on a L. mono-
cytogenes infection, were successfully drained and treated
with oral antibiotic therapy.10 After more than 8 years
follow-up, the patient died of lung carcinoma.
After EVAR, migration of the endograft and Type Ia endo-
leak have been shown to occur in up to 8.6% and 12.3% of the
cases, respectively.2,3 Treatment of these complications may
also be performed by an endovascular approach, but a short
infrarenal neck or even proximal extension beyond the renal
arteries limits the possibilities. The use of a custom-made
fenestrated endograft has good results, preventing the need
for open surgery.11
Treatment of the infected endograft would ideally mean
removal of the infected foreign bodies, but it carries con-
siderable mortality and morbidity risks.12 Not in all cases,
especially in endovascular prostheses, removal of infected
material is possible and sole treatment with antibiotics is an
option, especially with low virulent causative microorgan-
isms.13 The additional challenge in this case was a Type Ia
endoleak, requiring treatment to prevent rupture. Placement
of a fenestrated endograft in an infected area would imply
that the newly implanted device also becomes infected.
Cleansing accessible areas reduces the chance of bacterial
overgrowth. By treating the patient with amaintenance dose
of antibiotics, the infectious agent can be controlled, but
bacterial resistance can be a risk. The patient should be
monitored closely for device failure and relapse of infection
despite suppressive therapy.
Fenestrated EVAR for an infected infrarenal endograft and
concomitant Type Ia endoleak is technically feasible. Long-
term outcome is still unclear. Lifelong antibiotic treatment is
mandatory to suppress bacterial load from foreign endovas-
cular bodies.
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